Black Diamond Therapeutics Inc.

09/22/2024 | Press release | Distributed by Public on 09/22/2024 08:38

Black Diamond Therapeutics to Host Webcast Presentation of Initial Phase 2 BDTX-1535 Data in Patients With Recurrent EGFRm NSCLC